Johnson & Johnson
JNJ.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$825.47B
Close$
$193.00
13.1% downside
Current Fair Value
13.1% downsideOvervalued by 13.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $825.47 Billion |
|---|---|
| Enterprise Value | $855.14 Billion |
| Dividend Yield | $4.28 (2.02%) |
| Earnings per Share | $11.14 |
| Beta | 0.23 |
| Outstanding Shares | 2,407,400,000 |
Return
| Return on Equity | 24.76% |
|---|---|
| Return on Assets | 10.46% |
| Return on Invested Capital | 17.46% |
Valuation & Multiples
| P/E Ratio | 30.22 |
|---|---|
| PEG | -55783.94 |
| Price to Sales | 5.55 |
| Price to Book Ratio | 6.34 |
| Enterprise Value to Revenue | 8.73 |
| Enterprise Value to EBIT | 33.51 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.59 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 13, 2026
EPS Estimate
$2.11
Average shareholder expectationRevenue Estimate
$21.22 B
Average shareholder expectationNext Earnings Call
Expected Date
January 26, 2027
EPS Estimate
$2.43
Average shareholder expectationRevenue Estimate
$22.01 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Johnson & Johnson
138,200 employees
CEO: Alex Gorsky At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today...